ILMN
NasdaqIllumina, Inc.
Technology · Laboratory Analytical Instruments
Research view
Fundamentals · SEC EDGAR · FY 2025-12-28
Revenue & Earnings — fiscal year
$4.5B
2022
$4.6B
2023
$4.5B
2023
$4.4B
2024
$4.3B
2025
Snapshot
SEC EDGAR · FY 2025-12-28Revenue$4.3B
Net Income$850.0M
Gross Profit$2.9B
Oper Income$807.0M
EPS (dil)$5.45
Rev/sh$28.70
FCF/sh$6.15
Book/sh$18.00
Gross M66.1%
Oper M18.6%
Profit M19.6%
FCF M21.4%
ROE31.2%
ROA12.8%
ROIC25.5%
R&D/Rev22.3%
Rev Y/Y-0.7%
Rev 3Y CAGR-1.8%
EPS Y/Y170.9%
EPS 3Y CAGR—
FCF 3Y CAGR106.3%
Payout—
Div/sh—
Shs Chg Y/Y-1.9%
Current Ratio2.08
Quick Ratio1.72
Debt/Eq0.43
Int Coverage8.0×
Net Debt$246.0M cash
Total Debt$1.2B
Cash & Eq$1.4B
Total Assets$6.6B
Oper CF$1.1B
Capex$148.0M
Free CF$931.0M
Buybacks$742.0M
Equity$2.7B
Liabilities—
Shs Outstand0.15B
SectorTechnology
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $4.5B | $4.6B | $4.5B | $4.4B | $4.3B |
| Gross Profit | $3.2B | $3.0B | $2.7B | $2.9B | $2.9B |
| Operating Income | $-123.0M | $-4.2B | $-1.1B | $-833.0M | $807.0M |
| Net Income | $762.0M | $-4.4B | $-1.2B | $-1.2B | $850.0M |
| Diluted EPS | $5.04 | $-28.00 | $-7.34 | $-7.69 | $5.45 |
| Operating Cash Flow | $545.0M | $392.0M | $478.0M | $837.0M | $1.1B |
| Free Cash Flow | $337.0M | $106.0M | $283.0M | $709.0M | $931.0M |
COMMUNITY · $ILMN0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.